![Jack Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 807 276 $ in data 31/05/2026
Jack L.
Kaye is currently an Independent Director at Dyadic International, Inc. since 2015, an Independent Non-Executive Director at uniQure NV since 2016, a Director at DiaCarta, Inc. since 2022, and a Director at Tda Industries, Inc. since 2024.
Former positions include Independent Director at Keryx Biopharmaceuticals, Inc. from 2011 to 2016, Director at Balboa Biosciences, Inc., Independent Director at Tongli Pharmaceuticals (USA), Inc., and Partner at Deloitte LLP (New York) from 1978 to 2006.
Education includes undergraduate studies at Baruch College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
UNIQURE N.V. 0,04% | 30/06/2026 | 25.996 ( 0,04% ) | 741 666 $ | 31/05/2026 |
| 24/04/2026 | 81.201 ( 0,22% ) | 65 610 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| DYADIC INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 01/05/2015 |
| UNIQURE N.V. | Direttore/Membro del Consiglio | 15/06/2016 |
DiaCarta, Inc.
 DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Direttore/Membro del Consiglio | 07/04/2022 |
Tda Industries, Inc.
 Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Direttore/Membro del Consiglio | 01/02/2024 |
| Società | Posizione | Fine |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Direttore/Membro del Consiglio | 25/05/2016 |
| TONGLI PHARMACEUTICALS (USA), INC. | Direttore/Membro del Consiglio | 19/06/2009 |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Corporate Officer/Principal | 01/05/2006 |
Balboa Biosciences, Inc.
 Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Tda Industries, Inc.
Tda Industries, Inc. Wholesale DistributorsDistribution Services Manufactures roofing, siding, and insulation materials | Distribution Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Dyadic International, Inc.
 Dyadic International, Inc. Medical/Nursing ServicesHealth Services Manufactures genes and other biological products | Health Services |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Provides audit, consulting, tax and financial advisory services | Commercial Services |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics for central nervous system disorders | Health Technology |
Tongli Pharmaceuticals (USA), Inc.
 Tongli Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical and health care products | Health Technology |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
DiaCarta, Inc.
DiaCarta, Inc. BiotechnologyHealth Technology Operates as a translational genomics and precision molecular diagnostics company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
